BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fernández-Fierro A, Funes SC, Rios M, Covián C, González J, Kalergis AM. Immune Modulation by Inhibitors of the HO System. Int J Mol Sci 2020;22:E294. [PMID: 33396647 DOI: 10.3390/ijms22010294] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Hosokawa Y, Hosokawa I, Ozaki K. Nobiletin Decreases Inflammatory Mediator Expression in Tumor Necrosis Factor-Stimulated Human Periodontal Ligament Cells. Mediators Inflamm 2021;2021:5535844. [PMID: 34335088 DOI: 10.1155/2021/5535844] [Reference Citation Analysis]
2 Appetecchia F, Consalvi S, Berrino E, Gallorini M, Granese A, Campestre C, Carradori S, Biava M, Poce G. A Novel Class of Dual-Acting DCH-CORMs Counteracts Oxidative Stress-Induced Inflammation in Human Primary Tenocytes. Antioxidants (Basel) 2021;10:1828. [PMID: 34829699 DOI: 10.3390/antiox10111828] [Reference Citation Analysis]
3 Mancuso C. The brain heme oxygenase/biliverdin reductase system as a target in drug research and development. Expert Opin Ther Targets 2022;:1-14. [PMID: 35285395 DOI: 10.1080/14728222.2022.2052848] [Reference Citation Analysis]
4 Ryter SW. Heme Oxygenase-1: An Anti-Inflammatory Effector in Cardiovascular, Lung, and Related Metabolic Disorders. Antioxidants 2022;11:555. [DOI: 10.3390/antiox11030555] [Reference Citation Analysis]
5 Williams MM, Hafeez SA, Christenson JL, O'Neill KI, Hammond NG, Richer JK. Reversing an Oncogenic Epithelial-to-Mesenchymal Transition Program in Breast Cancer Reveals Actionable Immune Suppressive Pathways. Pharmaceuticals (Basel) 2021;14:1122. [PMID: 34832904 DOI: 10.3390/ph14111122] [Reference Citation Analysis]
6 Zhang Q, Wang L, Wang S, Cheng H, Xu L, Pei G, Wang Y, Fu C, Jiang Y, He C, Wei Q. Signaling pathways and targeted therapy for myocardial infarction. Signal Transduct Target Ther 2022;7:78. [PMID: 35273164 DOI: 10.1038/s41392-022-00925-z] [Reference Citation Analysis]
7 Dugbartey GJ. Carbon monoxide as an emerging pharmacological tool to improve lung and liver transplantation protocols. Biochem Pharmacol 2021;193:114752. [PMID: 34487717 DOI: 10.1016/j.bcp.2021.114752] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
8 Sun HJ, Wang ZC, Nie XW, Bian JS. Therapeutic potential of carbon monoxide in hypertension-induced vascular smooth muscle cell damage revisited: from physiology and pharmacology. Biochem Pharmacol 2022;:115008. [PMID: 35318039 DOI: 10.1016/j.bcp.2022.115008] [Reference Citation Analysis]
9 Dugbartey GJ, Alornyo KK, Luke PPW, Sener A. Application of carbon monoxide in kidney and heart transplantation: A novel pharmacological strategy for a broader use of suboptimal renal and cardiac grafts. Pharmacol Res 2021;173:105883. [PMID: 34525329 DOI: 10.1016/j.phrs.2021.105883] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
10 Costa M, da Costa V, Frigerio S, Festari MF, Landeira M, Rodríguez-Zraquia SA, Lores P, Carasi P, Freire T. Heme-Oxygenase-1 Attenuates Oxidative Functions of Antigen Presenting Cells and Promotes Regulatory T Cell Differentiation during Fasciola hepatica Infection. Antioxidants (Basel) 2021;10:1938. [PMID: 34943041 DOI: 10.3390/antiox10121938] [Reference Citation Analysis]